Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

This study has suspended participant recruitment.
(Restructuring of Cell Lab)
Sponsor:
Collaborator:
CBR Systems, Inc.
Information provided by (Responsible Party):
Florida Hospital
ClinicalTrials.gov Identifier:
NCT02038972
First received: January 8, 2014
Last updated: August 10, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)